Your session is about to expire
← Back to Search
DiVA for Vulvovaginal Atrophy
Study Summary
This trial is testing whether two different types of laser treatment can help with vulvovaginal symptoms. 100 people will be given one of four treatments, and then tested six and twelve months later to see if there are any improvements.
- Vulvovaginal Atrophy
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are elderly adults eligible for enrollment into this trial?
"The age requirements for potential candidates of this trial are between 40 and 65 years old."
Are there still vacancies available for participants in this research?
"Per evidence hosted on clinicaltrials.gov, this experiment is not recruiting new participants at the moment as it was last updated on February 4th 2022. Nonetheless, 187 other trials are presently enrolling people in need of medical care."
Do I fulfill the qualifications necessary to participate in this trial?
"This clinical trial calls for participants aged between 40 and 65 that have been diagnosed with atrophy. A total of 50 patients will be accepted into the program."
What are the key goals of this experiment?
"Over the course of 1.5 years, this clinical trial will be monitoring a Vaginal Laxity Questionnaire to measure progress. Additionally, female sexual function is being evaluated using the FSFI, incontinence is assessed with an IIQ-7 survey, and vaginal wall elasticity is measured through Zimmern Probes."
Share this study with friends
Copy Link
Messenger